<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>503A & 503B | Clinical Pharmacology Glossary</title>
  <style>
    body {
      font-family: 'Helvetica Neue', Arial, sans-serif;
      background-color: #f8fafc;
      color: #1e293b;
      margin: 0;
      padding: 0;
      line-height: 1.6;
    }

    header {
      background-color: #003366;
      color: white;
      text-align: center;
      padding: 1.5rem 0;
      font-size: 1.5rem;
      letter-spacing: 0.5px;
    }

    main {
      max-width: 900px;
      margin: 2rem auto;
      padding: 1rem 1.5rem;
      background-color: white;
      border-radius: 10px;
      box-shadow: 0 0 10px rgba(0,0,0,0.1);
    }

    h1 {
      color: #003366;
      text-align: center;
      margin-bottom: 1rem;
    }

    h2 {
      color: #00509e;
      margin-top: 1.5rem;
    }

    ul {
      padding-left: 1.5rem;
    }

    li {
      margin-bottom: 0.5rem;
    }

    .highlight {
      background-color: #e0f2fe;
      padding: 0.5rem;
      border-left: 4px solid #0073e6;
      margin: 1rem 0;
    }

    a {
      color: #0073e6;
    }

    footer {
      margin-top: 2rem;
      text-align: center;
      font-size: 0.9rem;
      color: #64748b;
      padding-bottom: 2rem;
    }

    .back-link {
      display: inline-block;
      margin-bottom: 1rem;
      text-decoration: none;
      color: #00509e;
      font-weight: bold;
    }

    .back-link:hover {
      text-decoration: underline;
    }

    .references {
      background: #f1f5f9;
      padding: 1rem;
      border-radius: 8px;
      margin-top: 2rem;
    }
  </style>
</head>
<body>

  <header>
    Clinical Pharmacology Glossary
  </header>

  <main>
    <a href="glossary.html" class="back-link">‚Üê Back to Glossary Index</a>
    <h1>What Are 503A and 503B?</h1>

    <p>Sections 503A and 503B of the Federal Food, Drug, and Cosmetic (FD&C) Act define two categories of compounding pharmacies under U.S. law.</p>

    <h2>üíä Section 503A ‚Äî Traditional Compounding Pharmacies</h2>
    <ul>
      <li><strong>Who they are:</strong> Local or community pharmacies that prepare custom medications for individual patients based on a prescription.</li>
      <li><strong>Purpose:</strong> To provide personalized drug formulations when commercial products don‚Äôt meet patient needs.</li>
      <li><strong>Key rules:</strong> Must be patient-specific; regulated mainly by state boards; not required to follow full FDA cGMP standards; cannot make drugs in bulk or for resale.</li>
    </ul>

    <h2>üíä Section 503B ‚Äî Outsourcing Facilities</h2>
    <ul>
      <li><strong>Who they are:</strong> Larger facilities that can compound sterile drugs in bulk without individual prescriptions.</li>
      <li><strong>Purpose:</strong> To supply hospitals, clinics, or offices with ready-to-use sterile preparations.</li>
      <li><strong>Key rules:</strong> Must register with the FDA, follow full cGMP, and are inspected regularly. Products are not FDA-approved for safety or efficacy.</li>
    </ul>

    <div class="highlight">
      <strong>In short:</strong>  
      503A = individualized, prescription-based compounding.  
      503B = large-scale, quality-controlled compounding under FDA oversight.
    </div>

    <h2>‚öóÔ∏è FDA-Approved vs 503B Compounded Drugs</h2>
    <ul>
      <li><strong>FDA-approved drugs:</strong> Require NDA/ANDA approval, supported by clinical trials and extensive safety and efficacy data.</li>
      <li><strong>503B drugs:</strong> Follow cGMP but do not undergo FDA approval or clinical testing before use.</li>
    </ul>

    <h2>üè≠ Is a 503B Facility Like a Small Factory?</h2>
    <p>Yes ‚Äî it operates like a small-scale manufacturer under cGMP, focused on compounding rather than drug innovation.</p>

    <h2>üè• Are 503B Facilities Independent?</h2>
    <p>Yes. Most are independent, though some large hospital systems operate their own registered outsourcing facilities.</p>

    <h2>‚ö†Ô∏è Why 503B Still Matters</h2>
    <p>503B facilities fill essential gaps in healthcare by ensuring sterile drug availability during shortages and enabling customized formulations for special clinical needs.</p>

    <h2>üßæ References</h2>
    <div class="references">
      <ul>
        <li><a href="https://www.fda.gov/drugs/human-drug-compounding/outsourcing-facilities" target="_blank">FDA ‚Äì Outsourcing Facilities (503B)</a></li>
        <li><a href="https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda" target="_blank">FDA ‚Äì Compounding and the FDA</a></li>
        <li><a href="https://www.fda.gov/media/94388/download" target="_blank">Drug Quality and Security Act (DQSA, 2013)</a></li>
      </ul>
    </div>
  </main>

  <footer>
    ¬© 2025 Crystal Yueng | Clinical Pharmacology Learning
  </footer>

</body>
</html>
